FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2132593721> ?p ?o ?g. }

• W2132593721 endingPage "2431" @default.
• W2132593721 startingPage "2426" @default.
• W2132593721 abstract "Copeptin levels are increased in patients diagnosed with stroke and other vascular diseases. Copeptin elevation is associated with adverse outcome, predicts re-events in patients with transient ischemic attack and is used in ruling-out acute myocardial infarction. We evaluated whether copeptin can also be used as a diagnostic marker in the prehospital stroke setting.We prospectively examined patients with suspected stroke on the Stroke Emergency Mobile-an ambulance that is equipped with computed tomography and point-of-care laboratory. A blood sample was taken from patients immediately after arrival. We analyzed copeptin levels in patients with final hospital-based diagnosis of stroke or stroke mimics as well as in vascular or nonvascular patients. In addition, we examined the associations of symptom onset with copeptin levels and the prognostic value of copeptin in patients with stroke.Blood samples of 561 patients were analyzed. No significant differences were seen neither between cerebrovascular (n=383) and other neurological (stroke mimic; n=90) patients (P=0.15) nor between vascular (n=391) and nonvascular patients (n=170; P=0.57). We could not detect a relationship between copeptin levels and time from onset to blood draw. Three-month survival status was available in 159 patients with ischemic stroke. Copeptin levels in nonsurviving patients (n=8: median [interquartile range], 27.4 [20.2-54.7] pmol/L) were significantly higher than in surviving patients (n=151: median [interquartile range], 11.7 [5.2-30.9] pmol/L; P=0.024).In the prehospital setting, copeptin is neither appropriate to discriminate between stroke and stroke mimic patients nor between vascular and nonvascular patients.URL: http://www.clinicaltrials.gov. Unique identifier: NCT01382862. The Pre-Hospital Acute Neurological Therapy and Optimization of Medical Care in Stroke Patients study (PHANTOM-S) was registered (NCT01382862). This sub-study was observational and not registered separately, therefore." @default.
• W2132593721 created "2016-06-24" @default.
• W2132593721 creator A5017769910 @default.
• W2132593721 creator A5023593253 @default.
• W2132593721 creator A5027602672 @default.
• W2132593721 creator A5035873637 @default.
• W2132593721 creator A5036289457 @default.
• W2132593721 creator A5043330113 @default.
• W2132593721 creator A5055838096 @default.
• W2132593721 creator A5069274834 @default.
• W2132593721 creator A5071809460 @default.
• W2132593721 creator A5075491461 @default.
• W2132593721 creator A5088444470 @default.
• W2132593721 creator A5090047862 @default.
• W2132593721 date "2015-09-01" @default.
• W2132593721 modified "2023-10-13" @default.
• W2132593721 title "Copeptin Levels in Patients With Acute Ischemic Stroke and Stroke Mimics" @default.
• W2132593721 cites W1598669383 @default.
• W2132593721 cites W1973435154 @default.
• W2132593721 cites W1987228313 @default.
• W2132593721 cites W1987959141 @default.
• W2132593721 cites W1988665849 @default.
• W2132593721 cites W2007326940 @default.
• W2132593721 cites W2022296035 @default.
• W2132593721 cites W2022792673 @default.
• W2132593721 cites W2042355814 @default.
• W2132593721 cites W2048120463 @default.
• W2132593721 cites W2056415370 @default.
• W2132593721 cites W2057150092 @default.
• W2132593721 cites W2071008229 @default.
• W2132593721 cites W2088794031 @default.
• W2132593721 cites W2089207725 @default.
• W2132593721 cites W2090249390 @default.
• W2132593721 cites W2098703751 @default.
• W2132593721 cites W2116157704 @default.
• W2132593721 cites W2121934996 @default.
• W2132593721 cites W2138148586 @default.
• W2132593721 cites W2140641748 @default.
• W2132593721 cites W2144352652 @default.
• W2132593721 cites W2158869546 @default.
• W2132593721 cites W25118065 @default.
• W2132593721 doi "https://doi.org/10.1161/strokeaha.115.009877" @default.
• W2132593721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26251255" @default.
• W2132593721 hasPublicationYear "2015" @default.
• W2132593721 type Work @default.
• W2132593721 sameAs 2132593721 @default.
• W2132593721 citedByCount "29" @default.
• W2132593721 countsByYear W21325937212016 @default.
• W2132593721 countsByYear W21325937212017 @default.
• W2132593721 countsByYear W21325937212018 @default.
• W2132593721 countsByYear W21325937212019 @default.
• W2132593721 countsByYear W21325937212021 @default.
• W2132593721 countsByYear W21325937212022 @default.
• W2132593721 countsByYear W21325937212023 @default.
• W2132593721 crossrefType "journal-article" @default.
• W2132593721 hasAuthorship W2132593721A5017769910 @default.
• W2132593721 hasAuthorship W2132593721A5023593253 @default.
• W2132593721 hasAuthorship W2132593721A5027602672 @default.
• W2132593721 hasAuthorship W2132593721A5035873637 @default.
• W2132593721 hasAuthorship W2132593721A5036289457 @default.
• W2132593721 hasAuthorship W2132593721A5043330113 @default.
• W2132593721 hasAuthorship W2132593721A5055838096 @default.
• W2132593721 hasAuthorship W2132593721A5069274834 @default.
• W2132593721 hasAuthorship W2132593721A5071809460 @default.
• W2132593721 hasAuthorship W2132593721A5075491461 @default.
• W2132593721 hasAuthorship W2132593721A5088444470 @default.
• W2132593721 hasAuthorship W2132593721A5090047862 @default.
• W2132593721 hasConcept C118552586 @default.
• W2132593721 hasConcept C119060515 @default.
• W2132593721 hasConcept C126322002 @default.
• W2132593721 hasConcept C127413603 @default.
• W2132593721 hasConcept C164705383 @default.
• W2132593721 hasConcept C2776370428 @default.
• W2132593721 hasConcept C2779311642 @default.
• W2132593721 hasConcept C2780645631 @default.
• W2132593721 hasConcept C2780724011 @default.
• W2132593721 hasConcept C500558357 @default.
• W2132593721 hasConcept C71924100 @default.
• W2132593721 hasConcept C78519656 @default.
• W2132593721 hasConceptScore W2132593721C118552586 @default.
• W2132593721 hasConceptScore W2132593721C119060515 @default.
• W2132593721 hasConceptScore W2132593721C126322002 @default.
• W2132593721 hasConceptScore W2132593721C127413603 @default.
• W2132593721 hasConceptScore W2132593721C164705383 @default.
• W2132593721 hasConceptScore W2132593721C2776370428 @default.
• W2132593721 hasConceptScore W2132593721C2779311642 @default.
• W2132593721 hasConceptScore W2132593721C2780645631 @default.
• W2132593721 hasConceptScore W2132593721C2780724011 @default.
• W2132593721 hasConceptScore W2132593721C500558357 @default.
• W2132593721 hasConceptScore W2132593721C71924100 @default.
• W2132593721 hasConceptScore W2132593721C78519656 @default.
• W2132593721 hasIssue "9" @default.
• W2132593721 hasLocation W21325937211 @default.
• W2132593721 hasLocation W21325937212 @default.
• W2132593721 hasOpenAccess W2132593721 @default.
• W2132593721 hasPrimaryLocation W21325937211 @default.
• W2132593721 hasRelatedWork W1990917846 @default.
• W2132593721 hasRelatedWork W2061253854 @default.

• next